<div id="readability-page-1"><p>Yatsen Holding Ltd. ((YSG)) has held its Q4 earnings call. Read on for the main highlights of the call.</p><h3>Claim 70% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <p>Yatsen Holding’s latest earnings call struck a cautiously upbeat tone as management highlighted a sharp rebound in revenue, a swing back to non‑GAAP profitability, and margin gains led by fast‑growing skincare brands. At the same time, executives acknowledged rising marketing costs, softness in color cosmetics, and negative operating cash flow that still cloud the company’s full recovery path.</p> <h2>Quarterly Revenue Growth</h2> <p>Fourth‑quarter 2025 net revenue rose 20.1% year over year to RMB 1.38 billion, in line with guidance and ahead of the broader beauty market. Management framed this as evidence that Yatsen is regaining share and executing effectively during key online shopping events despite a tougher competitive backdrop.</p> <h2>Full-Year Revenue Recovery</h2> <p>For full‑year 2025, total net revenue climbed 26.7% to RMB 4.3 billion, reversing the declines seen in 2024 and marking a return to top‑line expansion. The rebound suggests that Yatsen’s portfolio repositioning and channel strategies are gaining traction across major e‑commerce platforms.</p> <h2>Skincare-Led Expansion</h2> <p>Skincare remained the growth engine, with Q4 skincare revenue surging 51.9% and reaching 61.1% of quarterly net sales. For 2025 as a whole, skincare revenue jumped 63.5% and contributed 53% of total net revenue, underscoring Yatsen’s shift away from its historic reliance on color cosmetics.</p> <h2>Improved Profitability and Margin Trends</h2> <p>On a GAAP basis, Q4 swung to a modest net income of RMB 3.0 million, a sharp turnaround from a RMB 378.8 million loss a year earlier. For 2025, the net loss narrowed to RMB 92.4 million and the loss margin improved to 2.2%, while full‑year gross margin ticked up to 78.2% from 77.1%.</p> <h2>Non-GAAP Turnaround</h2> <p>Yatsen delivered a full‑year 2025 non‑GAAP net income of RMB 8.4 million, or a 0.2% margin, compared with a sizable non‑GAAP loss the previous year. This shift back into the black on an adjusted basis signals underlying operational improvement even as the company has yet to post sustained GAAP profits.</p> <h2>Operating Expense Discipline</h2> <p>Total operating expenses in Q4 fell 15.6% year over year to RMB 1.08 billion, and the opex ratio dropped to 78.6% of revenue from 111.8%. General and administrative costs were a particular bright spot, shrinking to 5.4% of revenue from 8.7%, pointing to tighter back‑office discipline.</p> <h2>Product &amp; Brand Highlights Driven by R&amp;D</h2> <p>Management spotlighted R&amp;D‑driven wins, including Galenic’s VB serum and Couture Revelation cream, which generated strong sales and industry awards. Dr. Wu’s PDRN serum launch and recognition as a growth breakthrough brand on Douyin underscored how Q4 R&amp;D spend, up 47.5% to RMB 38.8 million, is feeding a robust innovation pipeline.</p> <h2>No Goodwill Impairment This Year</h2> <p>Unlike the prior year, 2025 results were not weighed down by goodwill impairments, avoiding the RMB 403.1 million charge that previously hit earnings. This absence of non‑cash write‑downs helped materially improve reported operating results and clarified the underlying earnings picture for investors.</p> <h2>Color Cosmetics Softness</h2> <p>The legacy color cosmetics segment lagged, with Q4 revenue down 9.1% year over year and full‑year growth of only 1.9%. Management acknowledged that recovery in this category remains slow, emphasizing the need for further product refresh and brand work to stabilize this once‑core business.</p> <h2>High Selling and Marketing Spend</h2> <p>Selling and marketing expenses climbed to RMB 893.8 million in Q4, up from RMB 690.6 million, and rose to 64.8% of revenue. The spike was driven by higher traffic acquisition costs and intense promotional activity during major shopping festivals, pressuring marketing efficiency.</p> <h2>Decline in Non-GAAP Quarterly Profitability</h2> <p>Despite GAAP improvement, Q4 non‑GAAP net income slipped to RMB 41.2 million from RMB 107.0 million a year earlier, with the margin sliding to 3.0% from 9.3%. The quarter’s weaker adjusted profitability highlighted how elevated marketing intensity is eating into near‑term earnings.</p> <h2>Negative Operating Cash Flow and Lower Cash Balances</h2> <p>Operating cash flow turned negative, with net cash used in operating activities totaling RMB 69.4 million in Q4 and RMB 94.7 million for 2025. Cash, restricted cash, and short‑term investments fell to RMB 1.05 billion from RMB 1.36 billion, raising investor focus on liquidity and cash discipline.</p> <h2>Continued GAAP Loss on Full-Year Basis</h2> <p>Even with substantial progress, Yatsen still posted a GAAP net loss of RMB 92.4 million for 2025, translating to a 2.2% loss margin. Management positioned this as a narrowing gap to breakeven but acknowledged more work is needed to deliver consistent, sustainable profitability.</p> <h2>Competitive Pressure and Marketing Intensity</h2> <p>Executives repeatedly cited fierce competition during key shopping festivals as peers fought for online traffic through aggressive discounting and promotions. This environment forced Yatsen to boost marketing spend, which supported top‑line growth but constrained margin improvement in the short term.</p> <h2>Forward-Looking Guidance and Outlook</h2> <p>For the first quarter of 2026, Yatsen guided net revenue in a range of RMB 958.6 million to RMB 1.08 billion, implying 15% to 30% year‑over‑year growth. Management indicated that this outlook reflects their current view of market conditions and internal execution, signaling confidence in continued skincare‑led momentum despite ongoing competitive and cost pressures.</p> <p>Yatsen’s earnings call painted a picture of a beauty group firmly back on a growth track, powered by skincare innovation and tighter cost controls, yet still wrestling with cash outflows and heavy marketing spend. For investors, the story is one of a promising turnaround in progress, with future share performance likely hinging on the balance between sustaining revenue gains and converting them into durable profits and cash generation.</p></div>

<p>Yatsen Holding Ltd. reported a cautiously optimistic Q4 earnings call, highlighting a 20.1% revenue increase to RMB 1.38 billion and a return to non-GAAP profitability. Skincare brands drove growth, with Q4 skincare revenue up 51.9%. However, rising marketing costs and negative operating cash flow remain concerns. The company posted a GAAP net loss of RMB 92.4 million for 2025, despite improved margins and reduced operating expenses. Management acknowledged competitive pressures impacting profitability and emphasized the need for further product innovation in color cosmetics.</p>

- Yatsen Holding Ltd. reported Q4 2025 earnings, highlighting a 20.1% revenue increase year over year, driven by strong skincare sales.  
- Despite a return to non-GAAP profitability, the company faced challenges with rising marketing costs, negative cash flow, and softness in color cosmetics.  
- Looking ahead, Yatsen projects Q1 2026 revenue growth between 15% and 30%, reflecting optimism in its skincare-led strategy amid competitive pressures.

Yatsen Holding Earnings Call Signals Skincare-Led Turnaround